Local Institution

Wichita, Kansas 67214

0 studies enrolling now · 17 studies all time

What they study most

AIDS, Acute Coronary Syndromes, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Dyslipidemia, HIV Infections, Hypertension, Lung Cancer, Lung Neoplasms, Major Depressive Disorder

Studies at this site

• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel — Withdrawn before enrolling
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Abatacept With Methotrexate- Phase IIB — Completed
• PPAR - Combination With Metformin — Completed
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia — Completed
• A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate — Completed
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis — Completed
• Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. — Completed
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed